Inhibitory Effect of Mitoxantrone on Collagen Synthesis in Dermal Fibroblasts

다국어 초록 (Multilingual Abstract)

Background: Fibroblasts produce collagen molecules that support the structure of the skin. The decrease and hypersynthesis of collagen causes skin problems such as skin atrophy, wrinkles and scars.
Objective: The purpose of this study is to investigate the mechanism of mitoxantrone on collagen synthesis in fibroblasts.
Methods: Cultured fibroblasts were treated with mitoxantrone, and then collagen synthe- sis was confirmed by reverse transcription-polymerase chain reaction and Western blot. Results: Mitoxantrone inhibited the expression of type I collagen in fibroblasts at both the mRNA and protein levels. In the collagen gel contraction assay, mitoxantrone significantly inhibited gel contraction compared to the control group. Mitoxantrone inhibited trans- forming growth factor (TGF)-β-induced phosphorylation of SMAD3. Finally, mitoxan- trone inhibited the expression of LARP6, an RNA-binding protein that regulates collagen mRNA stability.
Conclusion: These results suggest that mitoxantrone reduces collagen synthesis by inhibit- ing TGF-β/SMAD signaling and LARP6 expression in fibroblasts, which can be developed as a therapeutic agent for diseases caused by collagen hypersynthesis.

참고문헌 (Reference)

1 Sato M, "Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids" 86 : 300-307, 2006

2 Frantz C, "The extracellular matrix at a glance" 123 (123): 4195-4200, 2010

3 Bettinger DA, "The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis" 98 : 827-833, 1996

4 Leask A, "TGF-beta signaling and the fibrotic response" 18 : 816-827, 2004

5 Thiele BJ, "RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis" 95 : 1058-1066, 2004

6 Shin JW, "Molecular mechanisms of dermal aging and antiaging approaches" 20 : 2126-, 2019

7 Evison BJ, "Mitoxantrone, more than just another topoisomerase II poison" 36 : 248-299, 2016

8 Zhang Y, "LARP6 meets collagen mRNA : specific regulation of type I collagen expression" 17 : 419-, 2016

9 Blackstock CD, "Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6expression and binding to the 5’ stem-loop of COL1a1 and COL1a2mRNA" 289 : 7264-7274, 2014

10 Zhou MW, "Inhibition of collagen synthesis by IWR-1 in normal and keloid-derived skin fibroblasts" 173 : 86-93, 2017

11 Gaidarova S, "Inhibition of basal and transforming growth factor-beta-induced stimulation of COL1A1 transcription by the DNA intercalators, mitoxantrone and WP631, in cultured human dermal fibroblasts" 277 : 38737-38745, 2002

12 Pushpakom S, "Drug repurposing : progress, challenges and recommendations" 18 : 41-58, 2019

13 Zhang T, "Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation" 129 : 110287-, 2020

14 Ngo P, "Collagen gel contraction assay" 341 : 103-109, 2006

15 Stefanovic L, "Characterization of binding of LARP6 to the 5’ stem-loop of collagen mRNAs : implications for synthesis of type I collagen" 11 : 1386-1401, 2014

16 Zhang QL, "Antitumor effect of albendazole on cutaneous squamous cell carcinoma(SCC)cells" 2019 : 3689517-, 2019

17 Akhmetshina A, "Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis" 3 : 735-, 2012